Question 1

What are the benefits of the dual-time point imaging compared to standard imaging?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 68Ga-PSMA PET/CT Imaging in Assessment of Prostate Cancer clinical trial (NCT05134064). Contact the study team or your healthcare provider for specific answers.

Question 2

How will the results of this imaging affect my treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 68Ga-PSMA PET/CT Imaging in Assessment of Prostate Cancer clinical trial (NCT05134064). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the risks or side effects associated with this imaging technique?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 68Ga-PSMA PET/CT Imaging in Assessment of Prostate Cancer clinical trial (NCT05134064). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for scans during this process?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 68Ga-PSMA PET/CT Imaging in Assessment of Prostate Cancer clinical trial (NCT05134064). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if the imaging shows new or worsening cancer?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 68Ga-PSMA PET/CT Imaging in Assessment of Prostate Cancer clinical trial (NCT05134064). Contact the study team or your healthcare provider for specific answers.

What this study is about